Eli Lilly and Company Price Today
Eli Lilly and Company
LLY
Healthcare
$531.82B
💰
Market Cap
78.1
💸
Price to Earnings
$7.2
🎉
EPS
+68
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
15 |
Strong Buy |
10 |
Hold |
5 |
Sell |
1 |
Strong Sell |
0 |
LLY Price Forecast Target
560.2 👉 710.0 +27%
LLY EPS Forecast
7.2 👉 12.6 +76%
Financials
Profit Margin
22 %
Revenue Growth
28.1 %
Dividend
$ 4.52
Held Percent
0.2% - Insiders
84.0% - Institutions
15.8% - Public
Major Fund Holders
-
💰 Lilly Endowment, Inc $56.0B
-
💰 Vanguard Group Inc $39.2B
-
💰 Blackrock Inc. $36.1B
-
💰 PNC Financial Services Group, Inc. $29.1B
-
💰 State Street Corporation $19.0B
Stock Ideas
Stanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcar…
Ray Dalio Portfolio
Ray Dalio, a visionary entrepreneur and investment strategist, laid the foundation of Bridgewater with a clear vision in mind. His relentless pursuit of excellence, coupled with an unwavering commitment to innovation, has propelled Bridgewater to be…
Ken Griffin Portfolio
Ken Griffin, the visionary founder of Citadel Investment Group, has transformed portfolio strategy with his innovative and tech-driven approach. Starting as a college student trading stock options, Griffin quickly rose to success and attracted signi…
Jim Chanos Portfolio
Jim Chanos is a revered figure in the world of portfolio management, known for his expertise in short selling and his pivotal role in uncovering fraud at Enron and WorldCom. Hailing from Milwaukee and a graduate of Yale with an economics degree, Ch…📮FAQ
Some Frequently Asked Questions.
The Eli Lilly and Company industry is Drug Manufacturers - General
The Eli Lilly and Company sector is Healthcare
The Eli Lilly and Company forecasted predicted Price to Earnings PE ratio is 44.3
The Eli Lilly and Company Price to Earnings PE ratio is 78.1
The Market Capitalization of Eli Lilly and Company is $531.82B
There are total of 897487590 float shares with 84.0% held by Institutions and 0.2% held by insiders
The MEli Lilly and Company forecasted Earnings per Share EPS is $12.6
The Eli Lilly and Company Earnings per Share EPS is 7.2
The Eli Lilly and Company company has $21911600000 gross profits with 22 profit margins
The Eli Lilly and Company Earnings Growth is 0.857% with 0.851% quarterly earnings growth
The Eli Lilly and Company Revenue is $29515499520 with 0.281 revenue growth
The price target for Eli Lilly and Company stock is $710.0 for the high target and $340.0 for the low target
The consensus analyst recommendations for Eli Lilly and Company is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Eli Lilly and Company is Buy, with the following breakdown:
- Buy: 15
- Strong Buy: 10
- Hold: 5
- Sell: 1
- Strong Sell: 0
The Beta of Eli Lilly and Company is 0.3
The dividend of Eli Lilly and Company is $4.52
The dividend yield of Eli Lilly and Company is 0.0081%
The biggest institutional and mutual fund holders of Eli Lilly and Company stock are
- Lilly Endowment, Inc
- Vanguard Group Inc
- Blackrock Inc.
- PNC Financial Services Group, Inc.
The Eli Lilly and Company ESG Score is 68, with the following breakdown:
- E: 3.43
- S: 17.4
- G: 11.56